Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

Rite Aid customers in Western New York say their prescriptions were transferred without permission — and now they’re stuck in ...

Society / Forget Kennedy’s faux-populist, anti-science approach. The former FTC chair provides the real model of an ideal HHS ...

For CVS, Q2 earnings will be a critical inflection point. A miss could trigger a breakup or further decline, making the stock ...

The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...

Recent health news highlights various developments, including Trump's spending bill impacting insurance costs, a major acquisition in the bioscience sector, and GSK's efforts to expand RSV vaccine ...

Using the Tufts Medicine Specialty Drug Evidence and Coverage Database (December 2023), we reviewed US-based guidelines for 389 drug-indication pairs, excluding oncology and biosimilar treatments.

This week in 5 numbers: Nearly a quarter of companies offer GLP-1 drug coverage for weight management Here’s a roundup of numbers from the last week of HR news — including how many director ...

Congress revives fight for coverage for Wegovy and other weight-loss drugs The Treat and Reduce Obesity Act bill could also ramp up federal support for obesity research efforts.

From a CVS subsidiary ordered to pay nearly $950 million in a false claims case to the Supreme Court upholding the ACA’s preventive coverage mandate, here are 12 healthcare industry lawsuits, ...

CVS Caremark stops coverage for Eli Lilly's weight loss drug Zepbound, citing high costs, while obesity specialists warn the decision disrupts patient treatment.